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Aims 
Better understanding of symptoms of myocardial ischaemia is needed to improve timeliness of treatment for acute coronary syndromes 
(ACS). Although researchers have suggested sex differences exist in ischaemic symptoms, meth-odological issues prevent conclusions. Using 
percutaneous coronary intervention (PCI) balloon inflation as a model of myocardial ischaemia, we explored sex differences in reported 
symptoms of ischaemia.
Methods and Conclusions 
Patients having non-emergent PCI, but not haemodynamic instability or left bundle branch block or non-acute cor-onary occlusion, were 
prospectively recruited. Pre-procedure, descriptions of pre-existing symptoms were obtained using open-ended questioning. Inflation was 
maintained for 2 min or until moderate discomfort or clinical instability occurred. During inflation, subjects were exhaustively questioned 
about their symptoms. Concurrent ECG data were collected. The final sample was 305 [39.7% women; mean age 63.9 (+10.6)]. No sex 
differences were found in rates of chest or typical ischaemic discomfort, regardless of ischaemic status. Women were significantly more likely 
to report throat/jaw discomfort [odds ratio: 2.91; 95% confidence interval: 1.58–5.37] even after statistical adjustment for clinical and 
demographic variables.
Conclusion 
This prospective study with ECG-affirmed ischaemia found no statistically significant differences in women’s and men’s rates of chest and 
other typical symptoms during ischaemia, although women were more likely to experience throat and jaw discomfort. Currently both 
popular press and some patient education materials suggest women experience myocardial ischaemia differently from men. Steps to ensure 
women and health professionals are alert for the classic symptoms of myocardial ischaemia in women, as well as men, may be warranted.
Observational studies have previously suggested sex-based differ-
ences in symptoms of myocardial ischaemia.1 – 10 Failure to effi-
ciently recognize ischaemic symptoms in women could partly 
explain delays in presentation,11 – 14 diagnosis, and lower rate of 
treatment to guidelines observed in women.8
Diagnosis of ischaemia using clinical history is limited by a 
patient’s recall of symptom characteristics, their inherent subjectiv-
ity, and by biases among care providers. Electrocardiographic ver-
ification of ischaemia for described episodes is usually unavailable. 
Even when obstructive coronary artery disease is conclusively 
documented, attributing index symptoms to the ischaemic 
substrate can be imprecise. Thus, there remains uncertainty as to
whether reported sex-based differences in ischaemic symptoms 
are due to biological differences, gender differences, patient or 
provider bias, flawed research methods, or other factors.
Few researchers have prospectively characterized sex-specific 
symptoms during objective ischaemia.15,16 Our objective, there-
fore, was to determine the nature of symptoms provoked by 
discrete episodes of ischaemia produced by transient coronary 
occlusion during percutaneous coronary intervention (PCI) and 
to determine, in this controlled setting, whether sex differences 
exist.17 – 20 To achieve this we employed a standardized balloon 
inflation protocol and concurrent questionnaire administration 
during routine PCI.
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Beginning in October 2003, potentially eligible patients at two 
university-affiliated centres in Vancouver, Canada were screened, 
including those undergoing scheduled elective (required within 
4 months) or urgent (required during current hospitalization) but 
not emergent (immediately) PCI, or coronary angiography with provi-
sional PCI. In the latter case, final eligibility required that a PCI was 
performed. Exclusions were (i) emergent PCI [evolving myocardial 
infarction (MI) or refractory ischaemia]; (ii) baseline occlusion of the 
target lesion [Thrombolysis in Myocardial Infarction (TIMI) grade 0 
or 1 flow] (iii) haemodynamic or electrical instability, or (iv) inability 
to converse in English. Participants were informed that the intent 
was to examine ischaemic symptoms provoked by PCI, but were 
blinded to the sex-specific nature of the analysis, to avoid reporting 
bias, and gave written, informed consent.
Assessment of symptoms
Before entering the catheterization laboratory, subjects were ques-
tioned using a standardized tool regarding the intensity (on a 0–10 
scale), location and quality of all symptoms they attributed to their 
heart that had led to their angiography or PCI referral (‘baseline’ symp-
toms). Overlapping patient-reported descriptors were later grouped 
using clinical and etymological knowledge (e.g. ‘across chest’ and ‘front 
of chest’ became ‘chest discomfort’; ‘heartburn’, ‘indigestion’ became 
‘epigastrium/indigestion/heartburn’). Analysis employed the commonly 
used taxonomy for ischaemic symptoms. Typical symptoms were 
defined as either: chest, arm(s), shoulder, jaw, back or epigastric discom-
fort; shortness of breath; diaphoresis; weakness; indigestion; nausea or 
vomiting; dizziness or lightheadedness; fear or restlessness.21 – 23
The PCI proceeded in standard fashion, except balloon inflation was 
prolonged to a maximum of 2 min so as to produce symptomatic and/
or electrocardiographic ischaemia. Throughout balloon inflation, sub-
jects were re-questioned about active symptoms using the same 
tool. Inflation was terminated before 2 min for greater than moderate 
symptom severity, or insipient electrical or haemodynamic instability.
Assessment of ischaemia
A multi-lead ECG recording (leads I, II, III, aVR, aVF, and either V2 or V3 
was obtained at baseline, immediately before balloon inflation, and 
immediately preceding balloon deflation, and the duration of balloon 
inflation was recorded. ST-segment deviation was measured manually 
in at least six ECG leads, including a precordial lead. Ischaemia was 
defined as any ST deviation of 1 mm or more in any lead.21
Statistics
Descriptive statistics were used to characterize the sample, number 
of symptoms, and the frequency of reporting symptoms. The Mann–
Whitney U test was used to compare the number of symptoms 
reported because of positive skewness. Bivariate analysis for sex differ-
ences in each reported symptom was conducted using either the x2 or 
Fisher’s exact test. To establish potential symptom predictors (other 
than sex), each symptom having a sex difference nearing statistical sig-
nificance (≤0.25)24 was subjected to further bivariate analysis of its 
relationship with clinical, demographic, and treatment characteristics: 
education, immigrant status, body mass index, procedure urgency, 
Canadian Cardiovascular Society (CCS) classification, procedure indi-
cation, renal dysfunction, pre-existing heart failure, pulmonary, liver/
gastrointestinal disease, malignancy, hypertension, hyperlipidaemia, dia-
betes, peripheral vascular disease, cerebrovascular disease, smoking
status, prior MI, prior PCI, prior coronary artery bypass grafting, and 
medications received within past 24 h [beta-blockers, intravenous 
nitroglycerin, long-acting nitrates, calcium antagonists, lipid-lowering 
agents, angiotensin-converting enzyme (ACE) inhibitors, aspirin, clopi-
dogrel, glyburide, hormone replacement therapy, anticoagulants, anti-
depressants]. Variables nearing significance (≤0.25) were entered en 
bloc into a multivariate logistic regression model as potential predic-
tors. Step-wise trimming of variables that were non-contributory 
(significance of .0.05) produced the most parsimonious model. To 
ensure that the final model was reliable, the minimum requirement of 
10 events per predictor variable was met.25
All analyses were conducted using the Statistical Package for the 
Social Sciences, version 16.0 (SPSS, Inc., Chicago, IL, USA). Power 
analysis indicated that, given a prevalence of chest or typical discomfort 
of 70% in men26 (alpha ¼ 0.05) a sample of 160 men and 160 women 
would provide 80% power to detect a statistically significant difference 
of 15% (alpha ¼ 0.05).27
Results
Sample characteristics
After receiving approval from local research ethics boards, the 
study was conducted over 51 months, ending in February 2008. 
Of 820 patients screened, 775 (94.5%) met inclusion criteria, of 
which 560 (72.3%) consented. Of those, 235 (42%) were ineligible 
after angiography: (PCI not undertaken, n ¼ 140; occluded target, 
n ¼ 95). Twenty subjects were excluded because of incomplete 
ECG data (n ¼ 13), incomplete interview data (n ¼ 5), or 
aborted PCI (n ¼ 2), yielding a final sample of 305 participants.
One hundred fifty-eight (51.8%) subjects were exposed to balloon 
inflation of .60 s and 120 (39.3%) had ,60 s [median (Mdn) 38 s, 
inter-quartile range (IQR) 23.5]; duration data were missing in 27 sub-
jects. Of those with duration .60 s, two men had ventricular arrhyth-
mias converted with a single countershock. There were no sex 
differences in the rate of complications. Reasons for early deflation 
were: worsening discomfort (12), worsening ST elevation (15), 
haemodynamic instability (1), premature ventricular contractions 
(1), and operator choice (2), but no reason for early deflation was 
reported in 89 cases. We examined all those who had early deflation 
but no ischaemia, and found there were no statistically significant 
sex/gender differences in frequencies. That is, women were not 
more likely than men to have inappropriate early deflation (i.e. for 
reasons other than ECG-verified ischaemia). In comparing the partici-
pants for whom no reason for early deflation was recorded with those 
for whom a reason was noted, differences were found only in the 
procedural urgency rating; those with no reason recorded were 
more likely to be ‘urgent’ cases.
Baseline characteristics are provided in Tables 1 and 2. Most were 
Canadian-born (70.5%), and spoke English as their first language 
(78.7%). Fifty-three per cent had CCS class III or IV angina and 
54.5% were undergoing angiography and PCI on an urgent inpatient 
basis. Women were older [65.8 (SD: 11.6) vs. 62.8 (SD: 9.9) years 
P ¼ 0.02] and were more likely to have a history of hypertension, 
cerebrovascular disease, or evidence of renal dysfunction.
Number of reported symptoms
Most subjects (75.7%) reported symptoms during balloon inflation. 
Women had significantly shorter balloon inflations (63.7 s vs. 73.6;
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t ¼ 2.99, P ¼ 0.003), but the rate of reporting at least one 
symptom did not differ significantly between men and women 
(73.9 vs. 80.2%; x2 ¼ 1.61, P ¼ 0.21). During the baseline inter-
view, women recalled a greater number of prior ischaemic symp-
toms than did men (Mdn 4, IQR 3, vs. Mdn 3, IQR 3, P ¼ 0.01). 
However, no difference in the number of symptoms reported 
during inflation was observed (Mdn 1, IQR 2, vs. Mdn 1, IQR 2, 
P ¼ 0.06) (Supplementary material online, Table S1).
Location of reported symptoms during
inflation
The raw data consisted of 202 unique symptom descriptors. 
Grouping of similar descriptors yielded 49 symptoms of which 
21 were described as the ‘main’ discomfort.
Unadjusted sex-specific findings
Chest discomfort was the most commonly reported symptom
overall (54.8%) (Table 3). There was no significant difference
between men and women in this, whether including only
symptoms reported as the ‘main’ symptom, or all reported symp-
toms. The overall prevalence of symptoms typical of myocardial
ischaemia was 69.8% (Table 4). Analysis, including either only
main symptoms, or all reported symptoms, indicated no significant
difference between men and women. Two symptoms were statisti-
cally significantly more prevalent in women: jaw/teeth/throat or
neck discomfort, and reporting only non-chest-pain discomfort.
Adjusted sex-specific findings
Symptoms with fewer than five reports or those not reaching stat-
istical significance of ,0.25 in bivariate analysis were not included
(Table 5). Adjustment for covariates did not substantially change
Table 1 Baseline characteristics, by sex
Characteristic All (N 5 305) Women (n 5 121) Men (n5 184) P-value
Socio-demographic
Age, mean (SD) 63.9 (10.7) 65.8 (11.6) 62.8 (9.9) 0.02
English as first language [n (%)] 240 (78.7) 94 (77.7) 146 (79.3) 0.73
Immigrant to Canada [n (%)] 90 (29.5) 28 (23.1) 62 (33.7) 0.05
Highest education (%)
Secondary or less 160 (52.4) 70 (57.9) 90 (48.9) 0.10
Post-secondary 145 (47.6) 51 (42.1) 94 (51.0)
Clinical
CCS angina class III or IV [n (%)] 163 (53.4) 63 (52.1) 100 (54.3) 0.46
Urgency of procedure [n (%)]
Elective 139 (45.6) 55 (45.5) 84 (45.7) 0.97
Urgent 166 (54.4) 66 (54.5) 100 (54.4)
Indication for procedure [n (%)]
ACS 131 (43.0) 53 (43.8) 78 (42.4) 0.81
Stable angina/CAD 174 (57.0) 68 (56.2) 106 (57.6) 0.84
Prior MI [n (%)] 109 (35.7) 38 (31.4) 71 (38.6) 0.20
Prior revascularization [n (%)]
PCI 72 (23.6) 28 (23.1) 44 (23.9) 0.88
CABG 18 (5.9) 5 (4.1) 13 (7.1) 0.28
Diabetes [n (%)]
Type I 2 (0.7) 2 (1.1) 0.15
Type II 58 (19.0) 20 (16.6) 38 (20.7) 0.37
Hypertension 198 (64.9) 88 (72.7) 110 (59.8) 0.02
Peripheral vascular disease 32 (10.5) 14 (11.6) 18 (9.8) 0.62
Cerebrovascular disease 22 (7.2) 14 (11.6) 8 (4.3) 0.02
eGFR ≤60 mL/min/1.73 m2a,b 68 (22.3) 42 (34.7) 26 (14.1) ,0.001
Hypercholesterolaemia 215 (70.5) 87 (69.6) 128 (71.9) 0.66
Liver/gastrointestinal disease 38 (12.5) 19 (15.7) 19 (10.3) 0.17
Pulmonary disease 18 (5.9) 11 (9.1) 7 (3.8) 0.06
Malignancy 42 (13.8) 18 (14.9) 24 (13.0) 0.20
CCS, Canadian Cardiovascular Society; ACS, acute coronary syndrome; CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention;
CABG, coronary artery bypass graft surgery.
aCalculated using Cockroft–Gault formula.
bSome missing data.
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the finding for jaw/teeth/throat or neck discomfort [adjusted odds
ratio (OR) 2.91; 95% confidence interval (CI) 1.58–5.37], but
female sex was no longer predictive of reporting only non-chest
pain discomfort (adjusted OR: 1.76; 95% CI: 0.91–3.40) after
adjustment for co-variates, specifically immigration status,
co-morbid peripheral vascular, renal or liver/gastrointestinal
disease, and prior use of clopidogrel. Restricting the analysis to
subjects with ECG-confirmed ischaemia (n ¼ 245) did not
change the findings substantially, although after adjustment,
female sex was a stronger predictor of jaw/teeth/throat or neck
discomfort (adjusted OR: 4.55; 95% CI: 2.31–8.98) than in the
whole sample, and remained a significant predictor of reporting
only non-chest discomfort (adjusted OR: 2.11; 95% CI: 1.09–
4.09). Factors that decreased the odds of reporting chest or
typical symptoms were: co-morbid peripheral vascular disease,
increasing age, and current clopidogrel therapy. Having immigrated
to Canada increased the odds of reporting chest discomfort.
Factors that increased the odds of reporting only non-chest
discomfort were peripheral vascular disease and current 
clopidogrel therapy. Increased reporting of jaw/teeth/throat or 
neck discomfort was associated with peripheral vascular disease 
and current clopidogrel, whereas decreased reporting of jaw/
teeth/throat or neck discomfort was predicted by having been an 
immigrant to Canada.
Discussion
This study is the first to prospectively examine sex-specific ischae-
mic cardiac symptoms caused by intentional transient reduction in 
regional coronary blood flow. We found no statistically significant 
differences in the frequency of ischaemia-induced chest discomfort 
or other typical ischaemic symptoms among women vs. men. 
However, women were significantly more likely to report throat, 
jaw and neck discomfort. No differences in frequency of back 
discomfort, a commonly cited sex difference, were found.
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Table 2 Procedural characteristics, by sex
Characteristic All (N 5 305) Women (n5 121) Men (n5 184) P-value
First vessel treated [n (%)]
Left anterior descending 115 (37.6) 44 (36.3) 71 (38.6) 0.88
Diagonal 8 (2.6) 4 (3.4) 4 (2.2) 0.86
Ramus 8 (2.6) 4 (3.3) 4 (2.2) 0.55
Circumflex 44 (14.4) 13 (10.8) 31 (16.8) 0.13
Obtuse marginal 27 (9.0) 10 (8.3) 17 (9.1) 0.97
Right coronary 100 (32.9) 45 (37.1) 55 (29.8) 0.24
Posterior descending 3 (1.0) 1 (0.8) 2 (1.1) 0.82
% Stenosis
Pre-PCI, mean (SD) (n ¼ 299) 83.0 (15.8) 82.0 (16.5) 83.7 (15.3) 0.37
Post-PCI, mean (SD) (n ¼ 292) 4.0 (10.5) 4.6 (9.7) 3.5 (11.1) 0.41
TIMI flow grade [n (%)] (n ¼ 275)
Pre-PCI
3 248 (81.3) 106 (87.6) 142 (77.2) 0.29
Post-PCI
3 270 (88.5) 112 (92.6) 158 (85.9) 0.35
Balloon inflation duration (s), mean (SD) 71.9 (31.8) 63.7 (37.1) 77.6 (40.8) ,0.01
PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction.
Table 3 Prevalence of chest discomfort, main or ever-reported symptom, during balloon inflation
Sex Chest discomfort as main





All (N ¼ 305) 167 (54.8) (45.4–65.5) 0.66 177 (58.0) (45.4–65.5) 0.60
Women (n ¼ 121) 64 (52.9) (45.4–65.5) 68 (56.2) (45.4–65.5)
Men (n ¼ 184) 103 (56.0) (45.4–65.5) 109 (59.2) (45.4–65.5)
CI, confidence interval.
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Sex differences in rates of chest 
discomfort or typical symptoms not 
found
Chest discomfort is the most widely recognized symptom of 
myocardial ischaemia, relied upon by both health professionals 
and the public.26,28 – 30 Sex-based differences in this symptom 
could have broad clinical and public health implications.
The similarity we observed between men and women in the 
frequency of chest discomfort and typical symptoms differs from 
some previous reports. A review of studies relying upon 
symptom recall found fewer women presented with chest discom-
fort than did men.26 However, several recent symptom-recall
studies, using both prospective and retrospective methods, have 
yielded no sex differences in this symptom31 – 37 and others, after 
adjusting for age, have found no sex differences in chest 
discomfort.1,3 – 5,7,38,39 Importantly, most of the aforementioned 
studies used retrospective review of health records or 
non-open-ended questionnaires (only allowing a pre-specified list 
of responses) administered days to weeks after the event. 
Closed, checklist-style questionnaires may favour reporting of 
more classical symptoms, and might discourage reporting symp-
toms not thought (by either patient or provider) to be typical. 
We note that, of 14 studies using open methods,33,34,36,40 – 42 all 
found no sex differences, whereas only two of eight studies 
using closed methods35,37 found no differences.
Table 5 Association of sex with selected symptoms reported during balloon inflation (men as referent)
Discomfort or symptom Sex Unadjusted
OR (95% CI)
Adjusted OR (95% CI)
 Women (%) (n 5 121) Men (%) (n 5 184)
Localized discomfort
Chest 69 (57.0) 111 (60.3) 0.87 (0.55–1.40) 1.21 (0.71–2.06) A, IMGR, PVD, CRB, CABG, GI, CLP
Arms (either/both) 11 (9.1) 17 (9.2) 0.98 (0.44–2.18) —b
Throat, jaw/teeth or neck 48 (38.0) 32 (17.4) 2.64 (1.53–4.57) 2.91 (1.58–5.37)A, IMMIG, CCS, PVD, CLP
Back/intrascapular 5 (4.1) 7 (3.8) 1.09 (0.34–3.52)a —b
Epigastric/indigestion 2 (1.7) 3 (1.6) 1.01 (0.17–6.16)a —c
Non-localized symptoms
Diaphoresis 4 (3.3) 3 (1.6) 2.06 (0.45–9.38)a —c
SOB 3 (2.5) 0 — —c
Weakness 2 (1.7) 2 (1.1) 1.53 (0.21–11.01)a —c
Nausea/vomiting 2 (1.7) 6 (3.3) 0.50 (0.09–2.51)a —c
Dizziness 2 (1.7) 1 (0.5) 3.08 (0.28–34.30)a —c
Restlessness/fear 0 0 — —c
Grouped symptoms
Only non-chest discomfort 29 (24.0) 27 (14.7) 1.83 (1.02–3.29) 1.76 (0.91–3.40)IMGR, PVD, GI, CLP
Any ‘typical’ symptoms 85 (70.2) 127 (69.0) 1.06 (0.64–1.75) 1.63 (0.89–2.96)PVD, CRB, PCI, LL
No discomfort 24 (19.8) 48 (26.1) 0.70 (0.40–1.22) 0.63 (0.35–1.14)A, LL
OR, odds ratio; CI, confidence interval; SOB, shortness of breath.
Significant co-variates: Aage; CCSCanadian Cardiovascular Society class CLPclopidogrel; CRBcerebrovascular disease; GIGI/liver disease; IMGRimmigrant; LLlipid-lowering therapy;
PCIprior percutaneous coronary intervention; PVDperipheral vascular disease.
aExact Fisher CI (expected cell frequency ,5).
bAdjusted analyses not reported if unadjusted P ≥ 0.25.
cAdjusted analysis not undertaken for event rates ,10.
Table 4 Prevalence of ‘typical’ symptoms, main or ever-reported, during balloon inflation
Sex ‘Typical’a symptoms as main
symptom [n (%)] (95% CI)
P-value ‘Typical’ symptoms
ever-reported [n (%)] (95% CI)
P-value
All (N ¼ 305) 199 (65.2) (55.53–75.14) 0.47 212 (69.5) (55.53–75.14) 0.82
Women (n ¼ 121) 76 (62.8) (55.53–75.14) 85 (70.2) (65.91–84.49)
Men (n ¼ 184) 123 (66.8) (55.53–75.14) 127 (69.0) (55.53–75.14)
CI, confidence interval.
aChest, arm(s), shoulder, jaw, back or epigastric discomfort; shortness of breath; diaphoresis; weakness; indigestion; nausea and/or vomiting; dizziness and/or lightheadedness; fear
or restlessness.
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Our prospective design, using consistent, iterative interrogation 
of symptoms during ischaemic episodes, eliminates recall bias. Our 
open-ended questioning may have aided more complete symptom 
reporting, thereby reducing sex/gender differences.43 Finally, col-
lection of electrocardiographic data during coronary occlusion to 
verify ischaemia overcomes another previously cited limitation.
Collateral flow, ischaemic pre-conditioning, and prior infarction 
may mitigate the development of ischaemia during temporary 
obstruction of coronary flow during balloon angioplasty. There-
fore, we examined our findings within the subgroup of 245 patients 
with electrocardiographically evident ischaemia during balloon 
inflation. Men and women did not differ with respect to ST 
changes, and there were no statistically significant sociodemo-
graphic or clinical differences between those with and without 
electrocardiographic ischaemia, though others have reported that 
ischaemia during PCI is more frequent and causes greater ST devi-
ation in women.44,45 Our findings of no sex differences in objective 
ischaemia may be due to the shorter inflation times to which the 
women were exposed. Notably though, our findings of no sex 
differences in chest or other typical symptoms were unchanged 
by this narrower analysis.
Women report greater number of
symptoms
Our observation at baseline that women recall more previous 
symptoms than men is concordant with the findings from studies 
in which data are based solely upon recall. Moreover, the differen-
tial we observed between recalled and prospectively triggered 
symptoms implies that women are more likely to report symptoms 
that are not actually part of their true ischaemic symptom array. It 
is possible though that the statistically significantly greater number 
of reported symptoms by women at baseline would have also been 
evident during balloon inflation if women had been exposed to 
inflations of equal duration. It has been previously suggested that 
women with ACS report more symptoms than men,40,42,46 
although such analyses have been infrequent. However, others have 
reported no differences.32,41,47,48 Psychosocial factors [e.g. socially 
prescribed gender roles, including the gender of the inter-viewer 
(research assistants in this study were predominantly women), 
different coping mechanisms, higher levels of anxiety, and higher 
prevalence of depression] may influence women’s ten-dency to 
report higher pain intensity,49 and may similarly explain the greater 
number of reported symptoms. Open- vs. closed-ended 
questioning, as mentioned, may also affect the number of symptoms 
reported.
Other symptoms
Throat, jaw, and neck discomfort were reported more by women, 
which is consistent with many previous studies.2,26,34 – 37,46,48,50,51 
The observation that women have greater vagal activity than 
men,52 and that the jaw area is innervated by the vagus nerve53,54 
may be clues to the mechanism underlying this observation.
As noted, women had shorter mean duration of balloon inflation 
than men and so were less likely to have had the full opportunity to 
develop ischaemia and symptoms. Consequently, it is possible that 
with longer duration, differential symptom profiles would have
emerged. Further study is warranted to ascertain whether this is 
the case.
Limitations
We did not measure gender in this study, though it is acknowl-
edged that gender (e.g. socially or culturally prescribed experi-
ences of ‘femaleness’ or ‘maleness’),55 as opposed to sex (biological 
characteristics such as anatomy)56 differences may explain some of 
the observed differences. We may have had insuf-ficient statistical 
power to detect some sex differences. However, the upper bounds 
of the odds ratio confidence intervals for chest pain were not large, 
suggesting that such differences, if present, are small, difficult to 
detect, and unlikely to be relevant in the assess-ment and 
management of individual patients. Studying a cohort referred for 
angiogram may have introduced biases, because those not referred 
may have had a higher prevalence of atypical symptoms.57 The 
duration of ischaemia induced during PCI is shorter than that of 
ACS or STEMI,21 and longer-lasting ischaemia might have elicited 
different or more symptoms. No measures of depression or 
anxiety were incorporated in the study, which have both been 
shown to be positively associated with pain.49 Because we did not 
systematically collect data about reasons for early balloon deflation, 
the extent to which other differences may have been present in this 
subset, and been a source of bias, is unknown. Finally, although our 
questionnaire possesses strong content-related validity, evidence 
for other types of validity has not yet been established.
Conclusions
In this sample of patients undergoing non-emergent PCI, no statisti-
cally significant differences were found between men and women in 
the prevalence of reporting chest or most other typical symp-toms. 
However, the findings revealed that women reported throat and 
jaw discomfort significantly more often than men. These findings 
add to the evidence that women report the typical symptoms of 
myocardial ischaemia with similar frequency to men. Efforts to 
emphasize differences between men’s and women’s symptoms of 
ischaemic heart disease, although well-intentioned, may be 
misguided.
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Supplementary material is available at European Heart Journal 
online.
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